Pharmaceutical regulatory data, drug approvals & compliance tracking
Home › Drug Pricing
Access detailed information about drug pricing data. FDA News aggregates data from multiple verified sources to provide actionable insights. Market conditions change rapidly, and staying informed is crucial for making sound decisions. This page aggregates the most relevant data points and presents them in an easily digestible format.
Historical data is available for trend analysis, allowing users to identify patterns and forecast future developments. The platform supports custom date ranges and filtering options for deeper analysis. Industry experts recommend monitoring these metrics on a monthly basis to stay ahead of market shifts. Our data shows significant movement in several key indicators over the past quarter.
This page is part of the FDA News data platform, which offers comprehensive coverage across related categories. Navigate using the links above to explore other sections.
| Drug | Category | List Price | Net Price | YoY Change |
|---|---|---|---|---|
| Insulin (avg) | Diabetes | $330 | $95 | -8% |
| Humira (adalimumab) | Autoimmune | $7,200 | $4,800 | -25% |
| Keytruda | Oncology | $12,500 | $10,200 | +5% |
| Ozempic | Diabetes/Obesity | $936 | $750 | +3% |
| Eliquis | Anticoagulant | $580 | $420 | -2% |
The complete dataset for this page is available in machine-readable JSON for developers and data pipelines — direct API endpoint, no auth, no page rendering required: https://fdanews.online/api/dataset/export?token=8879fa41752f34337e8716122e218242Full Data Export
